Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL5414031

O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.[Mo]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 2/20 0.44
CA13 Q8N1Q1 1/20 0.44
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA5A P35218 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
NT5E P21589 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA9 Q16790 1/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250523-B2 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2007-07-31 US disclosed
WO-2005086622-A2 IMIDO-TETHERED CARBENES OF MOLYBDENUM FOR RING-OPENING METATHESIS POLYMERISATION AND RING-CLOSING METATHESIS MICHIGAN STATE UNIVERSITY (US) 2005-09-22 WO disclosed
US-20050101475-A1 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101475-A1 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis NOXO1, PPOX, CBR1 ALDH1A1 4187/4885L3MBTL1 2049/4885CA1 3279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.